Linköping University Medical Dissertations, No. 1020
Errata
The Importance of CTLA-4 and HLA Class II for
Type 1 Diabetes Immunology
Carl-Oscar Jonson
Location Reads Should read
Page 4 Original publications I, II, III, IV
Publication III and IV should change place
Page 20, 3rd paragraph, line 4
“…in the presence of HLR…”
“…in the presence of HLA…”
Page 24, 2nd paragraph, line
3 “administrating long‐lasting insulin” “administrating short‐and long‐lasting insulin” Page 37, 2nd paragraph, line
1 “Thirty‐one” “Thirty”
Page 38, 2nd paragraph, line 1
“GAD65 peptide a.a. 247‐279,”
“GAD65 peptides a.a. 247‐279 and 524‐543” Page 43, 2nd paragraph, line
8 “DQ6 complicated due in” “DQ6 complicated in” Page 48, figure 19 Missing text “p=0.06 and AA, AG, GG” Page 57, 5th paragraph, line
1
“population of T1D patients are recruited”
“population of T1D patient recruitment”
Page 58, 2nd paragraph, line
3 “that mixed AG and” “than mixed AG and”
Page 58, 3rd paragraph, line
9 “that might used to” “that might be used to” Paper 1, page 188, Results,
4th paragraph, line 3 “DR3‐DQ2 and/or DQ4‐DQ8” “DR3‐DQ2 and/or DR4‐DQ8” Paper II, page 51, Real Time
PCR, line 1
“A number of 47 samples” “A number of 16 samples” Paper III, page 5, Study
population, 1st paragraph, line 1
“Blood samples from 31 children”
“Blood samples from 30 children”
Paper III, page 10, 2nd
paragraph, line 3 “children with CTLA‐4 +49AA (p=0.07)” “children with CTLA‐4 +49GG (p=0.07)” Paper III, page 14,
Acknowledgements Olle Eriksson is acknowledged from economical support
Olle Eriksson is
acknowledged for statistical support, not economical support.
2
Location Reads Should read
Paper III Figure legends Missing “Relative quantification of antigen specific IFN‐γ or IL‐4 out of 100.000 PBMC. Each individual is
represented by a triangle marking.”
Paper III, Table 2, Antigens Second GAD65 –peptide
missing GAD65 a.a. 524‐543 100pg/ml, Dept of Medical and Physiological chemistry, Uppsala University, Sweden Paper IV, Page 4,
Introduction, 2nd paragraph, line 9 “CTLA‐4 binds to B7/CD80/82” “CTLA‐4 binds to B7/CD80/86” Paper IV, Page 6, Material
and Methods, 2nd paragraph, line 11
“(a.a. 247‐279) and PHA, both”
“(a.a. 247‐279) (Dept of Medical and Physiological chemistry, Uppsala
University, Sweden) and PHA (Sigma, Stockholm, Sweden), both”
